Skip to main content
. 2012 Jan 8;21(7):1283–1289. doi: 10.1007/s00586-011-2135-5

Table 3.

GP management of new neck pain and LBP problems, proportion of problems that receive at least one of the listed management actions at encounter (CI%)

Management action New neck pain problem (%) (95% CI) (n = 3,070) New low back pain (%) (95% CI) (n = 5,675)
Medication advised/prescribed 58.1 (56.1–60.1) 64.8 (63.3–66.2)
 NSAID* 32.1 (30.3–33.8) 36.1 (34.7–37.5)
 Opioid total 11.5 (10.4–12.7) 18.6 (17.5–19.7)
  Codeine/Paracetamol 7.7 (6.7–8.7) 11.9 (11.0–12.8)
 Paracetamol 15.8 (14.4–17.1) 17.1 (16.0–18.2)
 Diazapam 3.2 (2.5–3.8) 2.3 (1.9–2.7)
 Topical (musculoskeletal) 3.7 (3.1–4.5) 2.8 (2.3–3.3)
 Muscle relaxants 0.3 (0.1–0.5) 0.1 (0.0–0.2)
Clinical treatments 20.3 (18.6–21.8) 23.1 (21.9–24.3)
 Sickness certificate 1.7 (1.2–2.1) 3.1 (2.6–3.6)
Procedures§ 25.1 (23.3–27.0) 18.5 (17.3––19.2)
Referrals (all) 20.3 (18.8–21.8) 16.5 (15.5–17.6)
 Allied health provider 17.6 (16.1–19.0) 15.0 (14.0–16.0)
  Physiotherapy 16.1 (14.7–17.5) 13.9 (12.9–14.9)
 Specialists 2.4 (1.8–2.9) 1.3 (1.0–1.6)
Imaging orders 22.8 (21.3–24.4) 24.1 (22.9–25.3)
 Diagnostic radiology orders 17.1 (15.7–18.5) 19.2 (18.1–20.3)
Pathology tests orders 2.1 (1.6–2.6) 4.2 (3.7–4.7)

* NSAID—non steroid anti-inflammatory agent

Codeine/paracetamol includes all combinations of codeine and paracetamol

Clinical treatments include advice, education, counselling, reassurance, administration

§Procedures include all physical treatments (i.e. manual therapy, injection and splinting)